These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1551496)

  • 1. Development of proliferative retinopathy in NIDDM. A follow-up study of American Indians in Oklahoma.
    Lee ET; Lee VS; Lu M; Russell D
    Diabetes; 1992 Mar; 41(3):359-67. PubMed ID: 1551496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetic retinopathy in Oklahoma Indians with NIDDM. Incidence and risk factors.
    Lee ET; Lee VS; Kingsley RM; Lu M; Russell D; Asal NR; Wilkinson CP; Bradford RH
    Diabetes Care; 1992 Nov; 15(11):1620-7. PubMed ID: 1468294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of renal failure in NIDDM. The Oklahoma Indian Diabetes Study.
    Lee ET; Lee VS; Lu M; Lee JS; Russell D; Yeh J
    Diabetes; 1994 Apr; 43(4):572-9. PubMed ID: 8138063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and progression of diabetic retinopathy in Koreans with NIDDM.
    Kim HK; Kim CH; Kim SW; Park JY; Hong SK; Yoon YH; Lee KU
    Diabetes Care; 1998 Jan; 21(1):134-8. PubMed ID: 9538984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The appearance of retinopathy and progression to proliferative retinopathy: the WHO Multinational Study of Vascular Disease in Diabetes.
    Keen H; Lee ET; Russell D; Miki E; Bennett PH; Lu M
    Diabetologia; 2001 Sep; 44 Suppl 2():S22-30. PubMed ID: 11587046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic retinopathy assessed by fundus photography in Pima Indians with impaired glucose tolerance and NIDDM.
    Nagi DK; Pettitt DJ; Bennett PH; Klein R; Knowler WC
    Diabet Med; 1997 Jun; 14(6):449-56. PubMed ID: 9212309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and determinants of elevated urinary albumin excretion in Pima Indians with NIDDM.
    Nelson RG; Knowler WC; Pettitt DJ; Hanson RL; Bennett PH
    Diabetes Care; 1995 Feb; 18(2):182-7. PubMed ID: 7729295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proliferative retinopathy in NIDDM. Incidence and risk factors in Pima Indians.
    Nelson RG; Wolfe JA; Horton MB; Pettitt DJ; Bennett PH; Knowler WC
    Diabetes; 1989 Apr; 38(4):435-40. PubMed ID: 2925007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A follow-up study of diabetic Oklahoma Indians. Mortality and causes of death.
    Lee ET; Russell D; Jorge N; Kenny S; Yu ML
    Diabetes Care; 1993 Jan; 16(1):300-5. PubMed ID: 8422796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High prevalence of diabetic retinopathy and nephropathy in Polynesians of Western Samoa.
    Collins VR; Dowse GK; Plehwe WE; Imo TT; Toelupe PM; Taylor HR; Zimmet PZ
    Diabetes Care; 1995 Aug; 18(8):1140-9. PubMed ID: 7587849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lower-extremity amputation. Incidence, risk factors, and mortality in the Oklahoma Indian Diabetes Study.
    Lee JS; Lu M; Lee VS; Russell D; Bahr C; Lee ET
    Diabetes; 1993 Jun; 42(6):876-82. PubMed ID: 8495811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severity of diabetic retinopathy is linked to lipoprotein (a) in type 1 diabetic patients.
    Guerci B; Meyer L; Sommer S; George JL; Ziegler O; Drouin P; Angioï-Duprez K
    Diabetes Metab; 1999 Nov; 25(5):412-8. PubMed ID: 10592864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The diagnosis of diabetic retinopathy. Ophthalmoscopy versus fundus photography.
    Lee VS; Kingsley RM; Lee ET; Lu M; Russell D; Asal NR; Bradford RH; Wilkinson CP
    Ophthalmology; 1993 Oct; 100(10):1504-12. PubMed ID: 8414411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and risk factors of severe non-proliferative/proliferative diabetic retinopathy: More than a decade follow up in the Tehran Lipids and Glucose Study.
    Sardarinia M; Asgari S; Hizomi Arani R; Eskandari F; Azizi F; Khalili D; Hadaegh F
    J Diabetes Investig; 2022 Feb; 13(2):317-327. PubMed ID: 34403198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and risk factors for diabetic retinopathy in the multiethnic population of Mauritius.
    Dowse GK; Humphrey AR; Collins VR; Plehwe W; Gareeboo H; Fareed D; Hemraj F; Taylor HR; Tuomilehto J; Alberti KG; Zimmet PZ
    Am J Epidemiol; 1998 Mar; 147(5):448-57. PubMed ID: 9525531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein (A) levels in type 2 diabetic patients with diabetic retinopathy.
    Ergün UG; Oztüzün S; Seydaoglu G
    Med J Malaysia; 2004 Aug; 59(3):406-10. PubMed ID: 15727389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of and risk factors for proliferative retinopathy and its association with blindness among diabetes clinic attenders.
    Janghorbani M; Jones RB; Allison SP
    Ophthalmic Epidemiol; 2000 Dec; 7(4):225-41. PubMed ID: 11262670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for development of retinopathy in elderly Japanese patients with diabetes mellitus.
    Araki A; Ito H; Hattori A; Inoue J; Sato T; Shiraki M; Orimo H
    Diabetes Care; 1993 Aug; 16(8):1184-6. PubMed ID: 8375248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of elevated IGF-I levels with increased retinopathy in late-onset diabetes.
    Dills DG; Moss SE; Klein R; Klein BE
    Diabetes; 1991 Dec; 40(12):1725-30. PubMed ID: 1756914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homocysteine as a risk factor for nephropathy and retinopathy in Type 2 diabetes.
    Looker HC; Fagot-Campagna A; Gunter EW; Pfeiffer CM; Narayan KM; Knowler WC; Hanson RL
    Diabetologia; 2003 Jun; 46(6):766-72. PubMed ID: 12774164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.